ClinicalTrials.Veeva

Menu

Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years? (U-PROTECT)

R

Region Örebro County

Status

Withdrawn

Conditions

Urinary Tract Infections
Incontinence-associated Dermatitis
Cognition Disorders in Old Age
Behavioral and Psychiatric Symptoms of Dementia
Urinary Incontinence

Treatments

Device: Use of Uricap Female, a New Urine Collecting Device

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the study is to evaluate if Uricap Female, an uridome for women, can be used instead of traditional incontinence aids to treat urinary incontinence (UI) among women 75 years and older.

Full description

The aim is to improve the care for female patients in long-term nursing homes who suffer from UI and to prevent recurrent urinary tract infections (UTIs).

The project organization consist of researchers within primary care, geriatrics and nursing sciences. The investigators will recruit study participants with UI from long-term nursing homes in Örebro County that will be randomized in an open randomised controlled trial to an intervention or a control group. The intervention will last for 3 months. The study participants will receive a structured medical assessment before and after the intervention, including assessment of the patient's cognitive functions, genital skin status, neuropsychiatric symptoms and quality of life (QoL).

The uridome is changed daily while the control group will receive usual incontinence treatment. The investigators will study the number of UTIs during the intervention period, analyze inflammatory cytokines in urine using OLINK proteomics and ELISA to study inflammation. Health economic analysis will be performed.

The investigators believe that treatment with Uricap Female will be more effective in preventing recurrent UTIs, improve genital skin status, cognitive status and neuropsychiatric symptoms and QoL for the women. This will directly lead to individualised care and less strain on primary care resources.

Sex

Female

Ages

75+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • UI that requires incontinence aids
  • Suitable anatomy (outer labia cover and protect the Uricap Female cup).

Exclusion criteria

  • active UTI
  • urinary retention (cannot empty the bladder on her own)
  • macroscopic hematuria
  • prolapse or similar gynecological disorders
  • allergy to silicone or latex (the material of Uricap Female)
  • short expected survival time

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Uricap group
Experimental group
Description:
the new incontinence device
Treatment:
Device: Use of Uricap Female, a New Urine Collecting Device
Control group
No Intervention group
Description:
the usual incontinence care

Trial contacts and locations

1

Loading...

Central trial contact

Zbigniew Dzialanski, MD; Yvonne Freund-Levi, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems